{"id":41676,"date":"2025-09-17T14:18:29","date_gmt":"2025-09-17T06:18:29","guid":{"rendered":"https:\/\/flcube.com\/?p=41676"},"modified":"2025-09-17T14:18:29","modified_gmt":"2025-09-17T06:18:29","slug":"suzhou%e2%80%91based-innobm-partners-with-qilu-pharmaceutical-on-bm601-metallic-embolic-microsphere","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41676","title":{"rendered":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere"},"content":{"rendered":"\n<p><strong>InnoBM Pharmaceuticals Co., Ltd.<\/strong> and <strong>Qilu Pharmaceutical Co.<\/strong> have inked a collaboration agreement to commercialize <strong>BM601<\/strong>, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive <strong>over 200\u202fmillion\u202fCNY<\/strong> in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-product-overview\">Product Overview<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>BM601<\/strong> \u2013 Developed entirely by InnoBM, the device stems from original research by Prof.\u202fZhuang\u202fLiu\u2019s team at Soochow University and carries its own intellectual\u2011property rights.<\/li>\n\n\n\n<li><strong>Mechanism<\/strong> \u2013 The microsphere delivers chemotherapy directly to the tumor vasculature while occluding blood flow, thereby enhancing drug concentration and reducing systemic exposure.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-clinical-impact\">Clinical Impact<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Early Trials<\/strong> \u2013 In patients with unresectable primary liver cancer, BM601 demonstrated significant clinical advantages over conventional TACE, including higher objective response rates and improved progression\u2011free survival.<\/li>\n\n\n\n<li><strong>Therapeutic Potential<\/strong> \u2013 The technology offers a more effective option for patients with intermediate and advanced\u2011stage liver cancer, addressing a critical unmet need in hepatocellular carcinoma management.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-strategic-value\">Strategic Value<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Qilu\u2019s Role<\/strong> \u2013 As a leading Chinese generic\u2011drug manufacturer, Qilu will leverage its global distribution network to bring BM601 to international markets, creating a new revenue stream for both companies.<\/li>\n\n\n\n<li><strong>Milestone Structure<\/strong> \u2013 The 200\u202fmillion\u202fCNY milestone framework aligns incentives with product performance, encouraging rapid commercialization and further clinical development.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41679,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[16,3593,208],"class_list":["post-41676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cancer","tag-innobm-pharmaceuticals","tag-qilu-pharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize BM601, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive over 200\u202fmillion\u202fCNY in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41676\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere\" \/>\n<meta property=\"og:description\" content=\"InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize BM601, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive over 200\u202fmillion\u202fCNY in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41676\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-17T06:18:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere\",\"datePublished\":\"2025-09-17T06:18:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1704.webp\",\"keywords\":[\"Cancer\",\"InnoBM Pharmaceuticals\",\"Qilu Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41676#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41676\",\"name\":\"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1704.webp\",\"datePublished\":\"2025-09-17T06:18:29+00:00\",\"description\":\"InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize BM601, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive over 200\u202fmillion\u202fCNY in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41676\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1704.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1704.webp\",\"width\":1080,\"height\":608,\"caption\":\"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41676#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere - Insight, China&#039;s Pharmaceutical Industry","description":"InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize BM601, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive over 200\u202fmillion\u202fCNY in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41676","og_locale":"en_US","og_type":"article","og_title":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere","og_description":"InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize BM601, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive over 200\u202fmillion\u202fCNY in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.","og_url":"https:\/\/flcube.com\/?p=41676","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-17T06:18:29+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41676#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41676"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere","datePublished":"2025-09-17T06:18:29+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41676"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41676#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp","keywords":["Cancer","InnoBM Pharmaceuticals","Qilu Pharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41676#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41676","url":"https:\/\/flcube.com\/?p=41676","name":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41676#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41676#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp","datePublished":"2025-09-17T06:18:29+00:00","description":"InnoBM Pharmaceuticals Co., Ltd. and Qilu Pharmaceutical Co. have inked a collaboration agreement to commercialize BM601, an innovative Class\u202fIII metallic embolic microsphere for Trans\u2011Arterial Chemoembolization (TACE) in liver cancer. Under the deal, InnoBM will receive over 200\u202fmillion\u202fCNY in milestone payments, plus sales commissions and revenue\u2011sharing from international markets.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41676#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41676"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41676#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp","width":1080,"height":608,"caption":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41676#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Suzhou\u2011Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1704.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41676"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41676\/revisions"}],"predecessor-version":[{"id":41680,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41676\/revisions\/41680"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41679"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}